{"version":"1.0","type":"link","title":"NEO-HYPORT: does neoadjuvant radiotherapy improve breast cancer outcomes? An open label, randomised, parallel group, superiority trial to compare the disease-free survival following neoadjuvant versus adjuvant hypofractionated radiotherapy in breast cancer (NEO-HYPORT).","author_name":"Chatterjee S 외","author_url":"https://prs-insight.online/author/Chatterjee%20S","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/75848","thumbnail_width":1200,"thumbnail_height":630}